Compare Dyne Therapeutics Inc. Common Stock (DYN) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs Warner Music Group Corp — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.08 (market cap $2.86B), while Warner Music Group Corp trades at $28.95 (market cap $15.12B). The key difference: Warner Music Group Corp is far larger — about 5.3× Dyne Therapeutics Inc. Common Stock's market cap, and Warner Music Group Corp pays a 2.77% dividend while Dyne Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and Warner Music Group Corp for 97 Days on average.
| DYN | WMG | |
|---|---|---|
Market Cap | $2.86B | $15.12B |
Volume | 3,341,579 | 1,464,172 |
Sector | Health | Media |
52-Week High | $26.78 | $34.72 |
52-Week Low | $14.60 | $23.65 |
Typical Hold Time | 0 Days | 97 Days |
Enterprise Value | $2.18B | $19.42B |
Dividend Yield | — | 2.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
Warner Music Group (WMG) trades at $28.91, up 0.91% on the day, with a bullish technical outlook and strong analyst consensus. Recent earnings show revenue growth to $6.71B in 2025, with net income of $365M, while Q3 2026 results are pending. The stock benefits from positive sentiment around AI partnerships and streaming growth, though it faces margin pressure from rising costs.
The investment outlook is positive, supported by a $39.50 analyst price target and institutional buying. Key opportunities include AI-driven content curation and market share gains, but risks involve competitive pressures and execution challenges amid leadership changes. The stock's current valuation at a P/E of 23.12 appears reasonable given growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
